All In MedTech

FDA Clearance Tracker · P960053-S004

SBI BRAUN-CUTTER TRAPEZ-METACARPAL PROSTHESIS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 28, 2007 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 28, 2007

Approved

Time to decision

35 days

Received Aug 24, 2007. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P960053-S004
Device name
SBI BRAUN-CUTTER TRAPEZ-METACARPAL PROSTHESIS
Applicant location
Selzach
Received
Aug 24, 2007
Decided
Sep 28, 2007
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P960053

Device type

Device class
Class III
Regulation
21 CFR 888.3220

Every decision under product code KWG

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT PROFESSIONAL CONTRACT STERILIZATION, TAUNTON, MASSACHUSETTS.

Source documents

Other decisions for Stryker Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.